The elementary strength of the study lies in the fact that it has observed the holistic effect of levothyroxine therapy on anthropometric measurements, serum adiponectin, insulin resistance, and cardiovascular risk scores in an adequate number of patients. This evidence concerns the gene ADIPOQ and Insulin resistance.